Focused Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-3,564
| Closed | -$37.2K | – | 843 |
|
2023
Q4 | $37.2K | Sell |
3,564
-132
| -4% | -$1.38K | 0.01% | 347 |
|
2023
Q3 | $37.7K | Sell |
3,696
-56
| -1% | -$571 | 0.01% | 328 |
|
2023
Q2 | $28.3K | Hold |
3,752
| – | – | 0.01% | 371 |
|
2023
Q1 | $33.2K | Buy |
3,752
+329
| +10% | +$2.91K | 0.01% | 364 |
|
2022
Q4 | $31.2K | Sell |
3,423
-735
| -18% | -$6.7K | 0.01% | 357 |
|
2022
Q3 | $34K | Hold |
4,158
| – | – | 0.01% | 326 |
|
2022
Q2 | $31K | Hold |
4,158
| – | – | 0.01% | 336 |
|
2022
Q1 | $39K | Hold |
4,158
| – | – | 0.01% | 335 |
|
2021
Q4 | $33K | Sell |
4,158
-1,000
| -19% | -$7.94K | 0.01% | 412 |
|
2021
Q3 | $50K | Sell |
5,158
-8,506
| -62% | -$82.5K | 0.01% | 373 |
|
2021
Q2 | $135K | Sell |
13,664
-19,903
| -59% | -$197K | 0.02% | 248 |
|
2021
Q1 | $387K | Buy |
33,567
+1,268
| +4% | +$14.6K | 0.07% | 112 |
|
2020
Q4 | $312K | Buy |
32,299
+2,637
| +9% | +$25.5K | 0.06% | 120 |
|
2020
Q3 | $267K | Sell |
29,662
-968
| -3% | -$8.71K | 0.06% | 122 |
|
2020
Q2 | $378K | Buy |
30,630
+638
| +2% | +$7.87K | 0.09% | 94 |
|
2020
Q1 | $269K | Buy |
29,992
+2,302
| +8% | +$20.6K | 0.08% | 101 |
|
2019
Q4 | $271K | Buy |
27,690
+622
| +2% | +$6.09K | 0.06% | 115 |
|
2019
Q3 | $186K | Sell |
27,068
-6,367
| -19% | -$43.8K | 0.05% | 147 |
|
2019
Q2 | $309K | Sell |
33,435
-7,372
| -18% | -$68.1K | 0.08% | 104 |
|
2019
Q1 | $640K | Sell |
40,807
-241
| -0.6% | -$3.78K | 0.19% | 71 |
|
2018
Q4 | $633K | Buy |
41,048
+2,494
| +6% | +$38.5K | 0.22% | 73 |
|
2018
Q3 | $830K | Sell |
38,554
-1,349
| -3% | -$29K | 0.28% | 62 |
|
2018
Q2 | $970K | Buy |
39,903
+902
| +2% | +$21.9K | 0.34% | 50 |
|
2018
Q1 | $667K | Buy |
39,001
+1,840
| +5% | +$31.5K | 0.21% | 72 |
|
2017
Q4 | $704K | Sell |
37,161
-24,136
| -39% | -$457K | 0.23% | 66 |
|
2017
Q3 | $1.08M | Buy |
61,297
+19,981
| +48% | +$352K | 0.36% | 47 |
|
2017
Q2 | $1.37M | Buy |
41,316
+9,381
| +29% | +$312K | 0.51% | 37 |
|
2017
Q1 | $1.03M | Buy |
31,935
+2,590
| +9% | +$83.1K | 0.4% | 43 |
|
2016
Q4 | $1.06M | Buy |
29,345
+11,445
| +64% | +$415K | 0.45% | 36 |
|
2016
Q3 | $824K | Buy |
17,900
+233
| +1% | +$10.7K | 0.36% | 42 |
|
2016
Q2 | $887K | Sell |
17,667
-280
| -2% | -$14.1K | 0.41% | 42 |
|
2016
Q1 | $960K | Sell |
17,947
-1,170
| -6% | -$62.6K | 0.52% | 40 |
|
2015
Q4 | $1.26M | Buy |
19,117
+687
| +4% | +$45.1K | 0.72% | 30 |
|
2015
Q3 | $1.04M | Buy |
18,430
+13
| +0.1% | +$734 | 0.66% | 34 |
|
2015
Q2 | $1.09M | Sell |
18,417
-852
| -4% | -$50.3K | 0.67% | 35 |
|
2015
Q1 | $1.2M | Sell |
19,269
-971
| -5% | -$60.5K | 0.74% | 31 |
|
2014
Q4 | $1.16M | Sell |
20,240
-926
| -4% | -$53.3K | 0.82% | 28 |
|
2014
Q3 | $1.14M | Sell |
21,166
-1,261
| -6% | -$67.8K | 0.87% | 29 |
|
2014
Q2 | $1.18M | Buy |
22,427
+520
| +2% | +$27.3K | 0.92% | 28 |
|
2014
Q1 | $1.16M | Buy |
21,907
+10,258
| +88% | +$542K | 0.97% | 24 |
|
2013
Q4 | $467K | Buy |
11,649
+5,386
| +86% | +$216K | 0.39% | 50 |
|
2013
Q3 | $237K | Buy |
+6,263
| New | +$237K | 0.23% | 68 |
|